No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
OPGN OpGen
- 2.5000
- +0.0100+0.40%
Close Jun 14 16:00 ET
- 2.5400
- +0.0400+1.60%
Post 19:18 ET
3.36MMarket Cap-60P/E (TTM)
2.5200High2.3401Low9.47KVolume2.4500Open2.4900Pre Close23.17KTurnover0.73%Turnover RatioLossP/E (Static)1.34MShares38.400052wk High-0.29P/B3.26MFloat Cap1.650052wk Low--Dividend TTM1.30MShs Float543999.5104Historical High--Div YieldTTM7.23%Amplitude1.6500Historical Low2.4470Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | OpGen Inc - Received Nasdaq Notice That Co Is Not in Compliance With Minimum Stockholders' Equity Requirement for Continued Listing on Nasdaq
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersViracta Therapeutics (NASDAQ:VIRX) stock increased by 16.8% to $0.68 during Tuesday's pre-market session. The company's market cap stands at $26.7 million. Purple Biotech (NASDAQ:PPBT) stock in
OpGen | 10-K: Annual report
OpGen Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q
PDF Version ROCKVILLE, Md., May 24, 2024 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, "OpGen" or "the Company") announced today that it received a notice from The Nasdaq Stock Market LLC ("Na
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
OpGen To Carry Out 1-for-10 Reverse Stock Split On May 20th, 2024
May 17th - $OpGen(OPGN.US)$ is about to implement a 1-for-10 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from May 20th, 2024.$OpGen(OPGN.US)$ rose 11.54% and
Comments
$OpGen(OPGN.US$ ROCKVILLE, Md., May 16, 2024 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN, "OpGen" or "the Company"))) today announced that the Company's board of directors has approved a 1-for-10 reverse stock split of its shares of common stock (the "Reverse Stock Split"). The Reverse Stock Split will become effective at 12:01 a.m. EST on May 20, 2024 and the Company's common stock will open for trading on The Nasdaq Capital Market on a post-split basis under the Company's e...
How David Lazar's Strategic Investment in OpGen Could Affect Your Portfolio.
In a move that has caught the attention of investors and industry observers alike, David E. Lazar, a seasoned private investor known for his keen eye for value, has recently made a significant investment in OpGen, Inc. (Nasdaq: OPGN). On March 25, 2024, Lazar acquired a substantial stake in the company, purchasing 200,000 shares of Series E Preferred Stock...
In a move that has caught the attention of investors and industry observers alike, David E. Lazar, a seasoned private investor known for his keen eye for value, has recently made a significant investment in OpGen, Inc. (Nasdaq: OPGN). On March 25, 2024, Lazar acquired a substantial stake in the company, purchasing 200,000 shares of Series E Preferred Stock...
$OpGen(OPGN.US$ 3/29/24 OpGen, Inc. has struck a deal with investor David E. Lazar, who will purchase 3 million shares of Series E Convertible Preferred Stock for $3 million. The initial payment of $200,000 has been made for 200,000 shares, with the rest to follow by May 1, 2024.
$OpGen(OPGN.US$ 🚀 for more gain
$OpGen(OPGN.US$ double bottom 🚀
1
3
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg